• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

融合F-FDG PET/CT的浅层和深层特征以预测非小细胞肺癌中的EGFR敏感突变。

Fusion of shallow and deep features from F-FDG PET/CT for predicting EGFR-sensitizing mutations in non-small cell lung cancer.

作者信息

Yao Xiaohui, Zhu Yuan, Huang Zhenxing, Wang Yue, Cong Shan, Wan Liwen, Wu Ruodai, Chen Long, Hu Zhanli

机构信息

Qingdao Innovation and Development Center, Harbin Engineering University, Qingdao, China.

Lauterbur Research Center for Biomedical Imaging, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.

出版信息

Quant Imaging Med Surg. 2024 Aug 1;14(8):5460-5472. doi: 10.21037/qims-23-1028. Epub 2024 Jan 19.

DOI:10.21037/qims-23-1028
PMID:39144023
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11320501/
Abstract

BACKGROUND

Non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor-sensitizing (EGFR-sensitizing) mutations exhibit a positive response to tyrosine kinase inhibitors (TKIs). Given the limitations of current clinical predictive methods, it is critical to explore radiomics-based approaches. In this study, we leveraged deep-learning technology with multimodal radiomics data to more accurately predict EGFR-sensitizing mutations.

METHODS

A total of 202 patients who underwent both flourine-18 fluorodeoxyglucose positron emission tomography/computed tomography (F-FDG PET/CT) scans and EGFR sequencing prior to treatment were included in this study. Deep and shallow features were extracted by a residual neural network and the Python package PyRadiomics, respectively. We used least absolute shrinkage and selection operator (LASSO) regression to select predictive features and applied a support vector machine (SVM) to classify the EGFR-sensitive patients. Moreover, we compared predictive performance across different deep models and imaging modalities.

RESULTS

In the classification of EGFR-sensitive mutations, the areas under the curve (AUCs) of ResNet-based deep-shallow features and only shallow features from different multidata were as follows: RES_TRAD, PET/CT . CT-only . PET-only: 0.94 . 0.89 . 0.92; and ONLY_TRAD, PET/CT . CT-only . PET-only: 0.68 . 0.50 . 0.38. Additionally, the receiver operating characteristic (ROC) curves of the model using both deep and shallow features were significantly different from those of the model built using only shallow features (P<0.05).

CONCLUSIONS

Our findings suggest that deep features significantly enhance the detection of EGFR-sensitizing mutations, especially those extracted with ResNet. Moreover, PET/CT images are more effective than CT-only and PET-only images in producing EGFR-sensitizing mutation-related signatures.

摘要

背景

表皮生长因子受体敏感(EGFR敏感)突变的非小细胞肺癌(NSCLC)患者对酪氨酸激酶抑制剂(TKIs)表现出阳性反应。鉴于当前临床预测方法的局限性,探索基于放射组学的方法至关重要。在本研究中,我们利用深度学习技术和多模态放射组学数据更准确地预测EGFR敏感突变。

方法

本研究纳入了202例在治疗前接受过氟-18氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(F-FDG PET/CT)和EGFR测序的患者。分别通过残差神经网络和Python包PyRadiomics提取深度和浅层特征。我们使用最小绝对收缩和选择算子(LASSO)回归选择预测特征,并应用支持向量机(SVM)对EGFR敏感患者进行分类。此外,我们比较了不同深度模型和成像模态的预测性能。

结果

在EGFR敏感突变分类中,基于ResNet的深度-浅层特征以及来自不同多数据的仅浅层特征的曲线下面积(AUC)如下:RES_TRAD,PET/CT>仅CT>仅PET:0.94>0.89>0.92;以及ONLY_TRAD,PET/CT>仅CT>仅PET:0.68>0.50>0.38。此外,使用深度和浅层特征的模型的受试者操作特征(ROC)曲线与仅使用浅层特征构建的模型的ROC曲线有显著差异(P<0.05)。

结论

我们的研究结果表明,深度特征显著增强了EGFR敏感突变的检测,尤其是用ResNet提取的特征。此外,PET/CT图像在生成与EGFR敏感突变相关的特征方面比仅CT图像和仅PET图像更有效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b86d/11320501/87b394498b97/qims-14-08-5460-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b86d/11320501/e9ec056c91a6/qims-14-08-5460-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b86d/11320501/cf0870bfd7b9/qims-14-08-5460-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b86d/11320501/74d62f5a9c54/qims-14-08-5460-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b86d/11320501/be3f5a25aac1/qims-14-08-5460-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b86d/11320501/d62db5ca187f/qims-14-08-5460-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b86d/11320501/87b394498b97/qims-14-08-5460-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b86d/11320501/e9ec056c91a6/qims-14-08-5460-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b86d/11320501/cf0870bfd7b9/qims-14-08-5460-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b86d/11320501/74d62f5a9c54/qims-14-08-5460-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b86d/11320501/be3f5a25aac1/qims-14-08-5460-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b86d/11320501/d62db5ca187f/qims-14-08-5460-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b86d/11320501/87b394498b97/qims-14-08-5460-f6.jpg

相似文献

1
Fusion of shallow and deep features from F-FDG PET/CT for predicting EGFR-sensitizing mutations in non-small cell lung cancer.融合F-FDG PET/CT的浅层和深层特征以预测非小细胞肺癌中的EGFR敏感突变。
Quant Imaging Med Surg. 2024 Aug 1;14(8):5460-5472. doi: 10.21037/qims-23-1028. Epub 2024 Jan 19.
2
Multimodal radiomics-based methods using deep learning for prediction of brain metastasis in non-small cell lung cancer withF-FDG PET/CT images.基于深度学习的多模态放射组学方法用于预测 F-FDG PET/CT 图像中的非小细胞肺癌脑转移。
Biomed Phys Eng Express. 2024 Sep 11;10(6). doi: 10.1088/2057-1976/ad7595.
3
Efficient 18F-fluorodeoxyglucose positron emission tomography/computed tomography-based machine learning model for predicting epidermal growth factor receptor mutations in non-small cell lung cancer.基于 18F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描的机器学习模型在非小细胞肺癌表皮生长因子受体突变预测中的应用。
Q J Nucl Med Mol Imaging. 2024 Mar;68(1):70-83. doi: 10.23736/S1824-4785.22.03441-0. Epub 2022 Apr 14.
4
Value of pre-therapy F-FDG PET/CT radiomics in predicting EGFR mutation status in patients with non-small cell lung cancer.治疗前F-FDG PET/CT影像组学在预测非小细胞肺癌患者表皮生长因子受体(EGFR)突变状态中的价值
Eur J Nucl Med Mol Imaging. 2020 May;47(5):1137-1146. doi: 10.1007/s00259-019-04592-1. Epub 2019 Nov 14.
5
Value of multi-center F-FDG PET/CT radiomics in predicting EGFR mutation status in lung adenocarcinoma.多中心 F-FDG PET/CT 影像组学预测肺腺癌中表皮生长因子受体突变状态的价值。
Med Phys. 2024 Jul;51(7):4872-4887. doi: 10.1002/mp.16947. Epub 2024 Jan 29.
6
Predicting EGFR mutation subtypes in lung adenocarcinoma using F-FDG PET/CT radiomic features.利用F-FDG PET/CT影像组学特征预测肺腺癌中的表皮生长因子受体(EGFR)突变亚型
Transl Lung Cancer Res. 2020 Jun;9(3):549-562. doi: 10.21037/tlcr.2020.04.17.
7
Performance of F-FDG PET/CT Radiomics for Predicting EGFR Mutation Status in Patients With Non-Small Cell Lung Cancer.F-FDG PET/CT 影像组学在预测非小细胞肺癌患者表皮生长因子受体突变状态中的应用
Front Oncol. 2020 Oct 8;10:568857. doi: 10.3389/fonc.2020.568857. eCollection 2020.
8
PET/CT Based EGFR Mutation Status Classification of NSCLC Using Deep Learning Features and Radiomics Features.基于PET/CT利用深度学习特征和放射组学特征对非小细胞肺癌进行表皮生长因子受体突变状态分类
Front Pharmacol. 2022 Apr 27;13:898529. doi: 10.3389/fphar.2022.898529. eCollection 2022.
9
Predicting PD-L1 expression status in patients with non-small cell lung cancer using [F]FDG PET/CT radiomics.使用[F]FDG PET/CT 影像组学预测非小细胞肺癌患者的 PD-L1 表达状态。
EJNMMI Res. 2023 Jan 22;13(1):4. doi: 10.1186/s13550-023-00956-9.
10
PET/CT Radiomic Features: A Potential Biomarker for EGFR Mutation Status and Survival Outcome Prediction in NSCLC Patients Treated With TKIs.PET/CT影像组学特征:非小细胞肺癌患者接受酪氨酸激酶抑制剂治疗时表皮生长因子受体突变状态及生存结果预测的潜在生物标志物
Front Oncol. 2022 Jun 21;12:894323. doi: 10.3389/fonc.2022.894323. eCollection 2022.

引用本文的文献

1
Prediction of oncogene mutation status in non-small cell lung cancer: a systematic review and meta-analysis with a special focus on artificial intelligence-based methods.非小细胞肺癌中癌基因突变状态的预测:一项系统综述和荟萃分析,特别关注基于人工智能的方法
Eur Radiol. 2025 Sep 8. doi: 10.1007/s00330-025-11962-x.
2
Exploring the critical role of SDHA in breast cancer proliferation: implications for novel therapeutic strategies.探索SDHA在乳腺癌增殖中的关键作用:对新型治疗策略的启示
Am J Transl Res. 2025 Jul 15;17(7):5221-5240. doi: 10.62347/XAKQ8090. eCollection 2025.
3
A comprehensive review on the cellular mechanism of traditional Chinese medicine in the treatment of pediatric lung diseases.

本文引用的文献

1
MLNAN: Multi-level noise-aware network for low-dose CT imaging implemented with constrained cycle Wasserstein generative adversarial networks.MLNAN:基于受限循环 Wasserstein 生成对抗网络的用于低剂量 CT 成像的多级噪声感知网络。
Artif Intell Med. 2023 Sep;143:102609. doi: 10.1016/j.artmed.2023.102609. Epub 2023 Jun 21.
2
Short-axis PET image quality improvement based on a uEXPLORER total-body PET system through deep learning.基于 uEXPLORER 全身 PET 系统的深度学习实现短轴 PET 图像质量改进。
Eur J Nucl Med Mol Imaging. 2023 Dec;51(1):27-39. doi: 10.1007/s00259-023-06422-x. Epub 2023 Sep 6.
3
Clinical application of F-fluorodeoxyglucose positron emission tomography/computed tomography radiomics-based machine learning analyses in the field of oncology.
中医药治疗小儿肺部疾病细胞机制的综合综述
Bioimpacts. 2025 Apr 6;15:30945. doi: 10.34172/bi.30945. eCollection 2025.
4
Optimized deep learning approach for lung cancer detection using flying fox optimization and bidirectional generative adversarial networks.使用狐蝠优化算法和双向生成对抗网络的肺癌检测优化深度学习方法。
PeerJ Comput Sci. 2025 May 27;11:e2853. doi: 10.7717/peerj-cs.2853. eCollection 2025.
5
Aptamers in Combination Therapies for Enhanced Radiosensitization in Cancer.用于增强癌症放射敏感性的联合疗法中的适配体
Iran J Biotechnol. 2025 Jan 1;23(1). doi: 10.30498/ijb.2025.491856.4032. eCollection 2025 Jan.
6
An explainable AI-driven deep neural network for accurate breast cancer detection from histopathological and ultrasound images.一种可解释的人工智能驱动的深度神经网络,用于从组织病理学和超声图像中准确检测乳腺癌。
Sci Rep. 2025 May 20;15(1):17531. doi: 10.1038/s41598-025-97718-5.
7
Liquid Biopsy for Medical Imaging Analysis in Cancer Diagnosis.用于癌症诊断中医学影像分析的液体活检
Curr Pharm Des. 2025;31(33):2635-2650. doi: 10.2174/0113816128371883250310174153.
8
Fine-tuned deep learning models for early detection and classification of kidney conditions in CT imaging.用于CT成像中肾脏疾病早期检测和分类的微调深度学习模型。
Sci Rep. 2025 Mar 28;15(1):10741. doi: 10.1038/s41598-025-94905-2.
9
Tumor microenvironment: recent advances in understanding and its role in modulating cancer therapies.肿瘤微环境:理解方面的最新进展及其在调节癌症治疗中的作用
Med Oncol. 2025 Mar 18;42(4):117. doi: 10.1007/s12032-025-02641-4.
10
Exosome-based miRNA delivery: Transforming cancer treatment with mesenchymal stem cells.基于外泌体的微小RNA递送:用间充质干细胞改变癌症治疗
Regen Ther. 2025 Feb 13;28:558-572. doi: 10.1016/j.reth.2025.01.019. eCollection 2025 Mar.
基于 F-氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描放射组学的机器学习分析在肿瘤学领域的临床应用。
Jpn J Radiol. 2024 Jan;42(1):28-55. doi: 10.1007/s11604-023-01476-1. Epub 2023 Aug 1.
4
Automatic brain structure segmentation for F-fluorodeoxyglucose positron emission tomography/magnetic resonance images via deep learning.通过深度学习实现F-氟脱氧葡萄糖正电子发射断层扫描/磁共振图像的自动脑结构分割
Quant Imaging Med Surg. 2023 Jul 1;13(7):4447-4462. doi: 10.21037/qims-22-1114. Epub 2023 Jun 8.
5
Unraveling mitochondria-targeting reactive oxygen species modulation and their implementations in cancer therapy by nanomaterials.解析线粒体靶向活性氧调节及其在纳米材料癌症治疗中的应用。
Exploration (Beijing). 2023 Apr 5;3(2):20220115. doi: 10.1002/EXP.20220115. eCollection 2023 Apr.
6
Revolving ATPase motors as asymmetrical hexamers in translocating lengthy dsDNA via conformational changes and electrostatic interactions in phi29, T7, herpesvirus, mimivirus, , and .作为不对称六聚体的旋转ATP酶马达,通过phi29、T7、疱疹病毒、巨型病毒等中的构象变化和静电相互作用来转运长双链DNA。
Exploration (Beijing). 2023 Feb 5;3(2):20210056. doi: 10.1002/EXP.20210056. eCollection 2023 Apr.
7
Nanodrugs with intrinsic radioprotective exertion: Turning the double-edged sword into a single-edged knife.具有内在辐射防护作用的纳米药物:将双刃剑变为单刃刀。
Exploration (Beijing). 2023 Mar 31;3(2):20220119. doi: 10.1002/EXP.20220119. eCollection 2023 Apr.
8
Recent advances in targeted antibacterial therapy basing on nanomaterials.基于纳米材料的靶向抗菌治疗的最新进展。
Exploration (Beijing). 2023 Feb 5;3(1):20210117. doi: 10.1002/EXP.20210117. eCollection 2023 Feb.
9
Advanced strategies to evade the mononuclear phagocyte system clearance of nanomaterials.逃避单核吞噬细胞系统对纳米材料清除的先进策略。
Exploration (Beijing). 2023 Jan 5;3(1):20220045. doi: 10.1002/EXP.20220045. eCollection 2023 Feb.
10
Radiomics in Lung Metastases: A Systematic Review.肺转移瘤的影像组学:一项系统综述。
J Pers Med. 2023 Jan 27;13(2):225. doi: 10.3390/jpm13020225.